BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 31562942)

  • 21. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
    Gerbaudo VH; Mamede M; Trotman-Dickenson B; Hatabu H; Sugarbaker DJ
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):810-21. PubMed ID: 21210110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.
    Quartuccio N; Evangelista L; Alongi P; Caobelli F; Altini C; Cistaro A; Lambertini A; Schiorlin I; Popescu CE; Linguanti F; Laudicella R; Scalorbi F; Di Pierro G; Asabella AN; Cuppari L; Margotti S; Lima GM; Scalisi S; Pacella S; Kokomani A; Ciaccio A; Sturiale L; Vento A; Cardile D; Baldari S; Panareo S; Fanti S; Rubini G; Schillaci O; Chiaravalloti A;
    Nucl Med Commun; 2019 Aug; 40(8):808-814. PubMed ID: 31136534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma.
    McLean LS; Cavanagh K; Hicks RJ; Callahan J; Xie J; Cardin A; Lim AM; Rischin D
    Cancer Imaging; 2021 Oct; 21(1):57. PubMed ID: 34645517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
    Yamaga E; Toriihara A; Nakamura S; Asai S; Fujioka T; Yoshimura R; Michi Y; Harada H; Tateishi U
    Jpn J Clin Oncol; 2018 Jul; 48(7):633-639. PubMed ID: 29718274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
    Concannon R; Larcos GS; Veness M
    J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
    Nøhr A; Gram SB; Charabi B; Tvedskov JF; Wessel I; Friborg J; Håkansson K; von Buchwald C; Fischer BM; Rasmussen JH
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2895-2902. PubMed ID: 31297609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract.
    Perlow A; Bui C; Shreve P; Sundgren PC; Teknos TN; Mukherji SK
    J Comput Assist Tomogr; 2004; 28(5):704-9. PubMed ID: 15480048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
    Alongi P; Picchio M; Zattoni F; Spallino M; Gianolli L; Saladini G; Evangelista L
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):464-73. PubMed ID: 26268680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
    Lai CH; Huang KG; See LC; Yen TC; Tsai CS; Chang TC; Chou HH; Ng KK; Hsueh S; Hong JH
    Cancer; 2004 Feb; 100(3):544-52. PubMed ID: 14745871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and prognostic value of
    Albano D; Zizioli V; Odicino F; Giubbini R; Bertagna F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):87-93. PubMed ID: 30573388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
    Alongi P; Caobelli F; Gentile R; Stefano A; Russo G; Albano D; Baldari S; Gilardi MC; Midiri M
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):224-233. PubMed ID: 27565154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R; Xiu Y; Zhuang HM; Alavi A
    Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
    van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
    Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG PET-CT in pediatric Langerhans cell histiocytosis.
    Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.